Your browser doesn't support javascript.
loading
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.
Toro, Camilo; Zainab, Mosufa; Tifft, Cynthia J.
Affiliation
  • Toro C; NIH Undiagnosed Diseases Program, NIH Common Fund, National Institutes of Health, Bethesda MD, United States.
  • Zainab M; Glycosphingolipid Disorders Unit, Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, United States.
  • Tifft CJ; NIH Undiagnosed Diseases Program, NIH Common Fund, National Institutes of Health, Bethesda MD, United States; Glycosphingolipid Disorders Unit, Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, United States.
Neurosci Lett ; 764: 136195, 2021 11 01.
Article in En | MEDLINE | ID: mdl-34450229
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Gangliosidoses, GM2 / Beta-Hexosaminidase alpha Chain / Beta-Hexosaminidase beta Chain / Enzyme Replacement Therapy Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Neurosci Lett Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Gangliosidoses, GM2 / Beta-Hexosaminidase alpha Chain / Beta-Hexosaminidase beta Chain / Enzyme Replacement Therapy Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Neurosci Lett Year: 2021 Document type: Article Affiliation country: Estados Unidos